Dr. Andrew Jay
Dr. Andrew Jay is Fund Head for the Medical Solutions Fund.
As Andrew is based in the U.S., he is an employee of Siemens Financial Services, Inc. and may not provide investment advice to any third parties.
Within the Med Fund Portfolio serves on the Board of Directors at U-Systems, and RadPharm. He previously sat on the board of Molecular Insight Pharmaceuticals and overseas the investments in MDdatacor, Zonare, Lifemasters and previously managed the Sequenom investment.
Prior to joining Siemens, Andrew was an I. I. ranked analyst following the medical technology industry at Alex Brown and Wachovia Securities. Sectors under coverage included imaging, orthopedics, cardiovascular, vision, diabetes, and neurologic devices.
During his career, he was instrumental in raising over $2 billion in equity capital for over 30 emerging growth medical technology companies including Boston Scientific, Perclose, Masimo, MediSense and Natus. He published over 10,000 pages of research including thought leading pieces on neurology, orthopedics and an early introduction to the then emerging field of drug coated stents.
Dr. Jay's prior experience includes leading consulting projects for Arthur D. Little and running his substantial dental practice. He has a Bachelor of Science from Rensselaer Polytechnic Institute, a DMD from the University of Pennsylvania and an MBA from the Kellogg School at Northwestern. Outside of the office Andrew is the founding Director of the Massachusetts Oyster Project.